Published in J Immunol on January 06, 2012
Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission. Viruses (2016) 0.84
Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission. PLoS Pathog (2014) 0.84
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid. J Neuroinflammation (2016) 0.81
The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis. Viruses (2015) 0.80
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: the particular context of virus infection. Cell Adh Migr (2012) 0.79
Phosphorylation of CRMP2 by Cdk5 Regulates Dendritic Spine Development of Cortical Neuron in the Mouse Hippocampus. Neural Plast (2015) 0.75
The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1). PLoS Pathog (2016) 0.75
Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth. AIDS Res Hum Retroviruses (2015) 0.75
Pooled genome wide association detects association upstream of FCRL3 with Graves' disease. BMC Genomics (2016) 0.75
Quantitative Phosphoproteomics Reveals a Role for Collapsin Response Mediator Protein 2 in PDGF-Induced Cell Migration. Sci Rep (2017) 0.75
CRMPs Function in Neurons and Glial Cells: Potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury. Mol Neurobiol (2016) 0.75
Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology (2013) 2.59
HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology (2006) 1.87
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci (2010) 1.45
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain (2010) 1.42
A benign form of neuromyelitis optica: does it exist? Arch Neurol (2011) 1.21
Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci (2007) 1.13
Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma. Proc Natl Acad Sci U S A (2013) 1.08
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies. Haematologica (2011) 1.06
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes. Hematol J (2004) 1.06
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood (2010) 1.05
HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J Clin Invest (2006) 1.03
Inactivation of hTERT transcription by Tax. Oncogene (2003) 1.01
An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays. PLoS One (2013) 1.01
Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy. Cancer Res (2005) 0.99
A role for the neuronal protein collapsin response mediator protein 2 in T lymphocyte polarization and migration. J Immunol (2005) 0.95
Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition. J Biol Chem (2008) 0.94
Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration. J Biol Chem (2009) 0.93
Long-term outcome of higher-risk MDS patients treated with azacitidine: an update of the GFM compassionate program cohort. Blood (2012) 0.91
Pro-inflammatory cytokines modulate matrix metalloproteinase secretion and organic anion transport at the blood-cerebrospinal fluid barrier. J Neuropathol Exp Neurol (2003) 0.91
Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo. Retrovirology (2010) 0.90
Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci (Landmark Ed) (2009) 0.90
High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys. Int J Cancer (2003) 0.89
Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes. Stem Cells Dev (2011) 0.89
Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents. Br J Haematol (2011) 0.88
Early and transient reverse transcription during primary deltaretroviral infection of sheep. Retrovirology (2008) 0.88
Heat Shock Protein 90 is overexpressed in high-risk myelodysplastic syndromes and associated with higher expression and activation of Focal Adhesion Kinase. Oncotarget (2012) 0.86
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Exp Hematol (2010) 0.84
Cause-specific telomere factors deregulation in hepatocellular carcinoma. J Exp Clin Cancer Res (2013) 0.83
Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion. Exp Hematol (2004) 0.83
Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication. Antimicrob Agents Chemother (2008) 0.83
Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1. Oncogene (2005) 0.82
Adult T-cell leukaemia/lymphoma-like human T-cell leukaemia virus-1 replication in infective dermatitis. Br J Haematol (2003) 0.82
A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses. J Infect Dis (2004) 0.81
Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression. Virology (2010) 0.81
Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J Neurochem (2005) 0.81
The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus). Antiviral Res (2006) 0.81
Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis. Haematologica (2005) 0.80
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions. Glia (2014) 0.80
Altered expression of CRMPs in the brain of bovine spongiform encephalopathy-infected mice during disease progression. Brain Res (2009) 0.79
HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells. Int J Cancer (2012) 0.79
Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line. Eur J Neurosci (2003) 0.79
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: the particular context of virus infection. Cell Adh Migr (2012) 0.79
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study. J Neurol Neurosurg Psychiatry (2012) 0.79
HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages. Environ Mol Mutagen (2005) 0.78
Mosaicism of HTLV-1 5' LTR CpG methylation in the absence of malignancy. Virus Res (2013) 0.78
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial. Hematol J (2002) 0.78
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Haematologica (2006) 0.78
Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology (2005) 0.77
How mRNA is misspliced in acute myelogenous leukemia (AML)? Oncotarget (2014) 0.77
Collapsin response-mediator protein 5 (CRMP5) phosphorylation at threonine 516 regulates neurite outgrowth inhibition. Eur J Neurosci (2014) 0.77
Naturally occurring substitutions of the human T-cell leukemia virus type 1 3' LTR influence strand-transfer reaction. J Virol Methods (2003) 0.77
Cumulative mutations in the genome of Echovirus 6 during establishment of a chronic infection in precursors of glial cells. Virus Genes (2005) 0.77
Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications. Ther Adv Neurol Disord (2010) 0.77
Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation. Exp Cell Res (2013) 0.76
Gelatin prepared from tuna skin: a risk factor for fish allergy or sensitization? Int Arch Allergy Immunol (2003) 0.76
Serum GFAP levels in optic neuropathies. J Neurol Sci (2012) 0.75
A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep. Retrovirology (2009) 0.75
Human corticotropin-releasing factor type 1 receptor analysis with white blood cells mRNAs and DNA. Mol Cell Endocrinol (2003) 0.75
Intrathecal synthesis of immunoglobulins in patients with unexplained intermediate uveitis. Ocul Immunol Inflamm (2010) 0.75
Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals. J Gen Virol (2012) 0.75
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome. J Neuroophthalmol (2016) 0.75
A 7.1 kbp beta-myosin heavy chain promoter, efficient for green fluorescent protein expression, probably induces lethality when overexpressing a mutated transforming growth factor-beta type II receptor in transgenic mice. Transgenic Res (2005) 0.75
HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa. J Clin Virol (2013) 0.75